about
Early detection of diabetic kidney disease: Present limitations and future perspectivesA Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational ModificationsAn Update on the Use of Animal Models in Diabetic Nephropathy ResearchPerspectives on systems biology applications in diabetic kidney diseaseApplications of urinary proteomics in biomarker discoveryEarly diabetic nephropathy in type 1 diabetes: new insightsProteomic candidate biomarkers of drug-induced nephrotoxicity in the ratUrinary collagen fragments are significantly altered in diabetes: a link to pathophysiologyPeptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkersA distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to enzyme replacement therapyDiabetic nephropathy - Epidemiology in Asia and the current state of treatmentMulticentric validation of proteomic biomarkers in urine specific for diabetic nephropathyEvolving pandemic diabetic nephropathyDiscovery of genes related to diabetic nephropathy in various animal models by current techniques.Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitisProteomic identification of early biomarkers of acute kidney injury after cardiac surgery in children.Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic PatientsClassical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications.Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuriaPlasma proteome analysis of patients with type 1 diabetes with diabetic nephropathyLinking transcriptomic and proteomic data on the level of protein interaction networks.Application of Proteomic Analysis to Renal Disease in the Clinic.Diabetic Nephropathy: New Risk Factors and Improvements in DiagnosisSources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of DiseaseEffects of hypertension and exercise on cardiac proteome remodellingUrine proteome analysis may allow noninvasive differential diagnosis of diabetic nephropathyProteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes.Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuriaFinding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis.Some views on proteomics in diabetes.Successes achieved and challenges ahead in translating biomarkers into clinical applications.Urinary peptides as a diagnostic tool for renal failure detected by matrix-assisted laser desorption/ionisation mass spectrometry: an evaluation of their clinical significance.Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease.Left ventricular diastolic function in relation to the urinary proteome: a proof-of-concept study in a general population.Uromodulin and α(1)-antitrypsin urinary peptide analysis to differentiate glomerular kidney diseases.Mass spectrometry in chronic kidney disease research.Proteomic discovery of diabetic nephropathy biomarkers.Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis.
P2860
Q26741494-327F97C9-731C-4200-9398-0C85A49C733DQ26769678-6DB1748D-A2F6-41A5-A600-149457528A09Q26774178-B65C420F-8562-4CC1-942C-7C54832D16D0Q26823206-4CC76F5C-A232-45F6-97C6-EC3498CA9C5CQ27010368-359E729C-519F-4405-800A-4B73BCFBA22FQ27021632-72DCDE68-EE44-4924-A508-851923C1BCC7Q27305109-650B392E-E329-48C3-A2EA-7F7ABB0D4E23Q28475613-A1B67F3F-2CAD-4FBE-BE00-992208A38461Q28477629-D055F3A0-DEF4-4E52-A110-9FF099B9B279Q28478586-F3302864-8FFB-4222-9A45-991328976BD8Q28742785-9C69D14D-885F-4408-B9D9-D60D7B00AA82Q28748796-E3CFE4DE-D7C2-4907-AC0C-C8B53A265D26Q30352538-33E03C97-56B4-43FB-8AB9-A0EA5433590AQ30398783-7FEC735E-B51F-43ED-9CDC-82712ABCF189Q30430034-22C190C5-2DA8-45A3-BE56-AF3CF76451EDQ30434677-A296E36F-605E-46D0-9756-2F1801A66737Q30985164-52873358-F898-4447-95AB-4B6D3411B1E5Q30992797-8D2AA7DC-B1A8-4FA4-BA15-CA97E72EED7BQ31148183-E306B9AF-04CF-44C6-B592-C29ED02322E0Q33436829-4BC9AD31-B2B3-4F4C-A729-982D8BEDB910Q33488868-F0851C51-AAB7-44A2-A8A4-67F2659CD7C8Q33537437-EE70C883-7F8B-4895-B7B2-5022298E56DEQ33568802-A690842B-F38C-4FB3-A190-FCAFF5CDF1A7Q33575004-F2444E38-9C84-491B-9CBD-7D1FE57D09A9Q33583018-3980ADE6-86A8-4AE2-A0FC-646A2F9FB606Q33597457-F2DBE465-09BF-4A58-9733-C51A5CCA13D1Q33616482-28812758-1B64-4801-9D7A-F3553A94EB9DQ33645242-B0892724-6B94-41C5-80A9-CEB297F85F2EQ33722952-2AD35689-1CFA-4F52-9E9A-2C763CF6F40EQ33735287-6F040A0D-2826-44F8-ABCA-8119DBDD36C2Q33764539-E6D25A2E-19FD-4C0C-9D58-5BB5C2DC7654Q33848339-09CC6EE6-72AD-484E-97D2-1C66EC10E75CQ33954585-AD2CA952-039E-4B28-893E-AC77016D0A82Q33986978-D3607D6B-EC68-411F-A515-B52B02134E15Q34129628-1BC1F5CD-EBA5-486D-9277-1E61327D2BD9Q34140378-5452D514-7BD6-49A1-8B95-C0D22E874674Q34187912-E056791C-A5B0-4D13-BB56-B33644BFEF61Q34313959-DFC37374-93AA-4564-9B69-34112DC4E092Q34330236-E180A50C-1691-4CB4-AF58-0A4EE5D263AAQ34369626-4EB62CAF-28F5-4680-AAFF-6479D0EC4101
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Urinary proteomics in diabetes and CKD
@ast
Urinary proteomics in diabetes and CKD
@en
type
label
Urinary proteomics in diabetes and CKD
@ast
Urinary proteomics in diabetes and CKD
@en
prefLabel
Urinary proteomics in diabetes and CKD
@ast
Urinary proteomics in diabetes and CKD
@en
P2093
P2860
P50
P356
P1476
Urinary proteomics in diabetes and CKD
@en
P2093
Bruce A Julian
David M Good
Joshua J Coon
Kasper Rossing
Mohammed Dakna
PREDICTIONS Network
P2860
P304
P356
10.1681/ASN.2007091025
P577
2008-04-30T00:00:00Z